\begin{savequote}[8cm]
  Quote goes here.
  \qauthor{--- James Wilson}
\end{savequote}

\chapter{\label{ch:5-isc-model-results}Results: Indian Subcontinent Models}
\minitoc

\section{Descriptive Analysis}

% flow diagram
\begin{figure}[tb]
  \centering
  \includegraphics[width = 0.9\textwidth, trim={4cm 0cm 2cm 2cm}, clip]{figures/ch5/isc_flow_chart.pdf}
  \caption[Indian subcontinent model: flow diagram]{Flow diagram showing the studies and patients excluded from Indian subcontinent model development, following application of the eligibility criteria. HIV: human immunodeficiency virus; IDDO: Infectious Diseases Data Observatory; ISC: Indian subcontinent; PKDL: post kala--azar dermal leishmaniasis; VL: visceral leishmaniasis.}
  \label{fig:isc_flow_diagram}
\end{figure}

On application of the eligibility criteria to the contributed studies in the IDDO VL data platform, a total of 19 studies and 4,599 patients were selected for inclusion. Full details are presented in the flow diagram (Figure \ref{fig:isc_flow_diagram}).

\subsection{Study Characteristics}

Key characteristics of the 19 included studies are presented in Table \ref{tab:isc_study}. Further study--level information, including full eligibility criteria, HIV testing, and definitions of initial cure and relapse, are presented in the \href{https://github.com/jpwil/dphil}{Supplementary Material}.

A median of 144 patients were recruited in each study, although this ranged considerably from 6 patients\cite{chakraborty2008} to 928 patients\cite{sundar2019} with an interquartile range (IQR) of 86.5--329.5 patients. Patients were recruited between 2000 and 2017 from sites in either India (15 studies, 4,171 (90.7\%) patients)\cite{bhattacharya2007,chakraborty2008, das2009,pandey2016,pandey2017,sundar2007a,sundar2008,sundar2008B,sundar2009,sundar2010,sundar2011,sundar2012,sundar2014,sundar2015,sundar2019} or Nepal (4 studies, 428 (9.3\%) patients)\cite{rijal2003, rijal2010a, rijal2010b}. All Nepalese studies were led by investigators based at the B.P. Koirala Institute of Health Sciences, a health sciences university in the city of Dharan, Koshi Province, eastern Nepal. All Indian studies recruited patients from the state of Bihar in northeastern India, with the majority of studies led by investigators from either a government referral hospital in Patna (Rajendra Memorial Research Institute of Medical Sciences: RMRIMS) (4 studies, 1,125 (24.5\%) patients)\cite{bhattacharya2007, das2009,pandey2016,pandey2017}, or a private research facility in Muzaffarpur (Kala--azar Medical Research Centre: KAMRC) (9 studies, 2,652 (57.7\%) patients)\cite{chakraborty2008,sundar2008,sundar2008B,sundar2009,sundar2010,sundar2011,sundar2012,sundar2015,sundar2019}.

% studies tables
\input{tables/ch5/isc_study.tex}

All studies recruited both male and female patients, and all but three studies reported age inclusion criteria. Of note, four studies only recruited patients aged $\geq$12 years (314 (6.8\%) patients)\cite{sundar2015,sundar2008B,sundar2008,rijal2010a}. Where specified, the lower age limit was otherwise between 2 and 6 years. One study (100 (2.2\%) patients) recruited children (<15 years) only. Otherwise, where specified, the upper age limit ranged from 60 to 70 years.

Twelve studies (2,021 (43.9\%) patients) explicitly reported performing HIV testing on all recruited patients\cite{bhattacharya2007,chakraborty2008,rijal2013,rijal2010a,sundar2007a,sundar2008,sundar2008B,sundar2009,sundar2010,sundar2014,sundar2015}, and patients with confirmed VL/HIV co-infection were excluded from all but two studies (280 (6.1\%) patients)\cite{rijal2003,rijal2010b}. Patients with HIV/VL co-infection from these two studies were excluded at the individual participant level, where reported.

In the 16 studies that reported a lower haemoglobin threshold for patient inclusion, the median threshold was 50g/dL (range 35 to 60g/dL)\footnote{with one study reporting boosting haemoglobin with blood transfusions prior to recruitment\cite{das2009}.}. Almost all studies reported excluding patients with serious illness, or the presence of significant co-existing diseases. Specific wording of the exclusion criteria, and additional limits for platelets, white blood cells, clotting, renal, and liver function, are presented in the \href{https://github.com/jpwil/dphil}{Supplementary Material}.

% study designs
% treatment arms

% definitions of initial cure
% definition of relapse

% relapse proportions


Relapse was identified in 228 (5.0\%) of all patients within 6--months of initial cure assessment.


\subsection{Individual Patient Characteristics}


% categorical variables table
\input{tables/ch5/isc_categorical.tex}

% continuous variables table
\input{tables/ch5/isc_continuous.tex}

% these are the study specific distributions of outcome, sex and age
% cp /Users/jameswilson/proj/vl_model_isc/figures/dist/main_dist.pdf figures/ch5/isc_main_dist.pdf
\newgeometry{left=1cm, bottom=2.5cm, right=2cm, top=3cm}
\begin{landscape}
  \begin{figure}[tb]
    \centering
    \includegraphics[width=1.35\textwidth]{figures/ch5/isc_main_dist.pdf}
    \caption{Graphical summary of the Indian subcontinent study-specific sample sizes and distributions of relapse status, sex, and age.}
    \label{fig:isc_main_dist}
  \end{figure}

  \begin{figure}[tb]
    \centering
    \includegraphics[width=1.35\textwidth]{figures/ch5/treat.pdf}
    \caption{Bar chart showing the distribution of treatment regimens across contributing studies from the Indian subcontinent. Drugs are colour-coded (see legend). Important distinguishing dosing information provided in the overlaying labels, as space allows. Full treatment details presented in Table \ref{tab:isc_study}. 6 patients are included from Chakraborty 2008: 5 receiving alternate day amphotericin B deoxycholate and 1 receiving human placenta extract. ABD: amphotericin B deoxycholate; ALT: alternate days; CONS: consecutive days; D: days; HPE: human placenta extract; MF: miltefosine; PENT: pentamidine; mg: miligrams/kilogram; SSG: sodium stibogluconate.}
    \label{fig:isc_treat}
  \end{figure}

\end{landscape}
\restoregeometry

\subsection{Pooled Univariable Distributions}


% pooled distributions of categorical variables
% cp /Users/jameswilson/proj/vl_model_isc/figures/dist/catOut/comb_cat.pdf figures/ch5/isc_cat_comb.pdf
\newgeometry{left=1cm, bottom=2.5cm, right=2cm, top=3cm}
\begin{landscape}
  \begin{figure}[tb]
    \centering
    \includegraphics[width=1.35\textwidth]{figures/ch5/isc_cat_comb.pdf}
    \caption{Pooled distributions and predictor--outcomes relationships for categorical candidate predictors. Excluding missing data. 95\% binomial confidence intervals calculated using the Wilson method. MF: miltefosine; Norm: normal; SDA: single-dose liposomal amphotericin B.}
    \label{fig:isc_cat_comb}
  \end{figure}
\end{landscape}
\restoregeometry


% these are the pooled continuous distributions and relationships with relapse - PART 1
% cp /Users/jameswilson/proj/vl_model_isc/figures/dist/contOut/age_comb.pdf figures/ch5/isc_pool_age_comb.pdf
% cp /Users/jameswilson/proj/vl_model_isc/figures/dist/contOut/ss_comb.pdf figures/ch5/isc_pool_ss_comb.pdf
% cp /Users/jameswilson/proj/vl_model_isc/figures/dist/contOut/fd_comb.pdf figures/ch5/isc_pool_fd_comb.pdf
% cp /Users/jameswilson/proj/vl_model_isc/figures/dist/contOut/height_comb.pdf figures/ch5/isc_pool_height_comb.pdf
% cp /Users/jameswilson/proj/vl_model_isc/figures/dist/contOut/weight_comb.pdf figures/ch5/isc_pool_weight_comb.pdf

\clearpage
\begin{figure}[H]
  \centering
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch5/isc_pool_age_comb.pdf}
      \put(2,19){\small Age}
    \end{overpic}
  \end{subfigure}
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch5/isc_pool_weight_comb.pdf}
      \put(2,19){\small Weight}
    \end{overpic}
  \end{subfigure}
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch5/isc_pool_height_comb.pdf}
      \put(2,19){\small Height}
    \end{overpic}
  \end{subfigure}
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch5/isc_pool_fd_comb.pdf}
      \put(2,19){\small FevDur}
    \end{overpic}
  \end{subfigure}
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch5/isc_pool_ss_comb.pdf}
      \put(2,19){\small SpnSize}
    \end{overpic}
  \end{subfigure}
  \caption{Distributions and predictor--outcome relationships for continuous non-laboratory candidate predictors. FevDur:~duration of fever; SpnSize:~spleen size. For each candidate predictor, left upper panel shows the overall density pooled across studies and the left lower panel shows overlapping densities normalised by relapse status. The right panel shows a univariable generalised additive model spline fit, with 95\% confidence interval, of relapse.}
  \label{fig:isc_pooled_dist_cont_lab}
\end{figure}

% these are the pooled continuous distributions and relationships with relapse - PART 2
% cp /Users/jameswilson/proj/vl_model_isc/figures/dist/contOut/wbc_comb.pdf figures/ch5/isc_pool_wbc_comb.pdf
% cp /Users/jameswilson/proj/vl_model_isc/figures/dist/contOut/plt_comb.pdf figures/ch5/isc_pool_plt_comb.pdf
% cp /Users/jameswilson/proj/vl_model_isc/figures/dist/contOut/hb_comb.pdf figures/ch5/isc_pool_hb_comb.pdf
% cp /Users/jameswilson/proj/vl_model_isc/figures/dist/contOut/alt_comb.pdf figures/ch5/isc_pool_alt_comb.pdf
% cp /Users/jameswilson/proj/vl_model_isc/figures/dist/contOut/cr_comb.pdf figures/ch5/isc_pool_cr_comb.pdf
\begin{figure}[H]
  \centering
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch5/isc_pool_hb_comb.pdf}
      \put(2,19){\small Hb}
    \end{overpic}
  \end{subfigure}
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch5/isc_pool_plt_comb.pdf}
      \put(2,19){\small Plt}
    \end{overpic}
  \end{subfigure}
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch5/isc_pool_wbc_comb.pdf}
      \put(2,19){\small WBC}
    \end{overpic}
  \end{subfigure}
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch5/isc_pool_alt_comb.pdf}
      \put(2,19){\small ALT}
    \end{overpic}
  \end{subfigure}
  \begin{subfigure}{\textwidth}
    \centering
    \begin{overpic}[width=\textwidth]{figures/ch5/isc_pool_cr_comb.pdf}
      \put(2,19){\small Crt}
    \end{overpic}
  \end{subfigure}
  \caption{Pooled distributions and predictor--outcome relationships for continuous laboratory candidate predictors. All predictors presented on log scale. Hb:~haemoglobin; Plt:~platelet; WBC:~white blood cells; ALT:~alanine aminotransferase; Crt:~creatinine. For each candidate predictor, left upper panel shows the overall density pooled across studies and the left lower panel shows overlapping densities normalised by relapse status. The right panel shows a univariable generalised additive model spline fit, with 95\% confidence interval, of relapse.}
  \label{fig:isc_pooled_dist_cont_nolab}
\end{figure}

\subsection{Missing Data Patterns}
% missing data figure
% cp /Users/jameswilson/proj/vl_model_isc/figures/missing/summary.pdf figures/ch5/isc_missing_summary.pdf
\begin{figure}[tb]
  \centering
  \includegraphics[scale = 0.8]{figures/ch5/isc_missing_summary.pdf}
  \caption{Density plot illustrating the amount of missing data overall and across contributing studies from the Indian subcontinent. Study ordered by lead author and year of publication (or protocol). Variables ordered by amount of missingness. ALT: alanine aminotransferase; WBC: white blood cells.}
  \label{fig:isc_missing_summary}
\end{figure}

\section{Model Results}

% cp /Users/jameswilson/proj/vl_model_isc/results/var_forest_combined.pdf figures/ch5/var_forest_combined.pdf
\begin{figure}[tb]
  \centering
  \includegraphics[width=\textwidth]{figures/ch5/var_forest_combined.pdf}
  \caption{Forest plot of adjusted odds ratios with 95\% confidence intervals for final model predictors. Odds ratios are displayed on a logarithmic scale. For age, the odds ratio represents a combination of linear and quadratic effects for standardised age (centred by the mean and scaled by the standard deviation). Please refer to Figure \ref{fig:isc_adjusted_assoc} for a visualisation of the adjusted relapse probabilities after recalibration of the model intercepts to the observed relapse rate observed in Sundar 2019\cite{sundar2019}.}
  \label{fig:isc_var_forest_combined}
\end{figure}

% cp /Users/jameswilson/proj/vl_model_isc/figures/multiAssocM1.pdf figures/ch5/isc_multiassoc_with_pg.pdf
% cp /Users/jameswilson/proj/vl_model_isc/figures/multiAssocM2.pdf figures/ch5/isc_multiassoc_without_pg.pdf
\newgeometry{left=2.5cm, bottom=2.5cm, right=2cm, top=3cm}
\begin{landscape}
  \begin{figure}[tb]
    \centering
    \begin{subfigure}{1.4\textwidth}
      \centering
      \begin{overpic}[width=\textwidth]{figures/ch5/isc_multiassoc_without_pg.pdf}
        \put(2,31){\small ISC model: without parasite grade}
      \end{overpic}
    \end{subfigure}
    \begin{subfigure}{1.4\textwidth}
      \centering
      \begin{overpic}[width=\textwidth]{figures/ch5/isc_multiassoc_with_pg.pdf}
        \put(2,26){\small ISC model: with parasite grade}
      \end{overpic}
    \end{subfigure}
    \caption{Adjusted associations between final predictors and predicted relapse probability, as estimated from the final ISC prognostic models. Probabilities were calculated from optimism-adjusted models and following logistic recalibration (intercept--term only) to data contributed from Sundar 2019\cite{sundar2019}. Where not varying in the plot, predictions are standardised to a representative reference participant: median age (18 years), median fever duration (30 days), treated with single-dose liposomal amphotericin B (10 mg/kg), with severe anaemia, and \textemdash\ for the model including parasite grade \textemdash\ a median parasite count of 2+.}
    \label{fig:isc_adjusted_assoc}
  \end{figure}
\end{landscape}
\restoregeometry

% calibration plots (overall)
% cp /Users/jameswilson/proj/vl_model_isc/graphs/calPlot.pdf figures/ch5/isc_calPlot.pdf
\begin{figure}[tb]
  \centering
  \begin{overpic}[width=\textwidth]{figures/ch5/isc_calPlot.pdf}
    \put(2,52){\small ISC model: with parasite grade}
    \put(50,52){\small ISC model: without parasite grade}
  \end{overpic}
  \caption{Calibration plots showing observed versus predicted probabilities for deciles of predicted probability. Red dashed line represents perfect calibration.  Observed probabilities are presented with 95\% confidence intervals (black error bars). A generalised additive model is fitted to show the smoothed mean observed probability (blue dotted line) with 95\% confidence intervals (blue ribbon). Histograms, normalised by outcome, are overlaid to illustrate the distribution of relapses and cures across the expected probabilities.}
  \label{fig:isc_calPlot}
\end{figure}

% calibration plots (parasite grade and fever duration)
% cp /Users/jameswilson/proj/vl_model_isc/graphs/calPlotFD1.pdf figures/ch5/isc_calPlotFD1.pdf
\begin{figure}[tb]
  \centering
  \includegraphics[width=\textwidth]{figures/ch5/isc_calPlotFD1.pdf}
  \caption{Calibration plots for different fever durations (model including parasite grade).}
  \label{fig:isc_calPlotFD1}
\end{figure}

\begin{table}[htbp]
  \begin{tabular}{@{}llll@{}}
    \toprule
                                   & Estimate (95\% CI) & Average  & Optimism--adjusted \\
                                   &                    & optimism & performance        \\
    \midrule
    \textbf{Model: with PG}        &                    &          &                    \\
    \hspace{1em} C-statistic       & 0.70 (0.66--0.74)  & 0.014    & 0.68               \\
    \hspace{1em} Calibration slope & 1.01 (0.69--1.32)  & 0.093    & 0.91               \\        \midrule
    \textbf{Model: without PG}     &                    &          &                    \\
    \hspace{1em} C-statistic       & 0.69 (0.64--0.74)  & 0.016    & 0.67               \\
    \hspace{1em} Calibration slope & 1.02 (0.68--1.35)  & 0.098    & 0.92               \\        \bottomrule
  \end{tabular}
  \caption{Apparent and optimism--adjusted performance measures. Abbreviations: CI: confidence interval; PG: parasite grade}
  \label{tab:isc-performance}
\end{table}

% cp /Users/jameswilson/proj/vl_model_isc/graphs/forestCIM1.pdf figures/ch5/forestCIM1.pdf
% forest plots for C-statistic
\begin{figure}[tb]
  \centering
  \begin{overpic}[width=\textwidth, trim={3.5cm 0cm 1cm 0.3cm}, clip]{figures/ch5/forestCIM1.pdf}
    \put(0,5.5){\fcolorbox{black}{white}{\scriptsize $\tau^2$ = 0; $I^2$ = 0\%; p = 0.73}}
  \end{overpic}
  \caption{Forest plot showing individual and pooled study c--statistics, for the model \textbf{including} parasite grade. For the model excluding parasite grade refer to Appendix \ref{fig:isc_forestCIM2}. Pooled c--statistics are presented from both fixed--effects and random--effects meta-analysis models, after excluding studies with $\leq$5 relapse events. Study--specific confidence intervals with few events should be interpreted with caution (as discussed in the Methodology\ref{meth:discrimination}). Blue diamonds: pooled summary estimates with 95\% confidence intervals. For Chakraborty 2008, no relapse events occurred and c--statistic is therefore undefined.}
  \label{fig:isc_forestCIM1}
\end{figure}

% cp /Users/jameswilson/proj/vl_model_isc/graphs/forestCalM1.pdf figures/ch5/forestCalM1.pdf
% forest plots for calibration
\begin{figure}[tb]
  \centering
  \begin{overpic}[width=\textwidth, trim={3.3cm 0cm 0.3cm 0.3cm}, clip]{figures/ch5/forestCalM1.pdf}
    \put(0,13){\fcolorbox{black}{white}{\scriptsize CITL: $\tau^2$ = 0.094; $I^2$ = 46.1\%; p = .01}}
    \put(0,9.52){\fcolorbox{black}{white}{\scriptsize CS: $\tau^2$ = 0; $I^2$ = 0\%; p = .74}}
  \end{overpic}
  \caption{Forest plots showing individual and pooled study calibration measures for the model \textbf{including} parasite grade. Left: calibration intercept (calibration--in--the--large, CITL); Right: calibration slope (CS). Blue diamonds: summary estimates with 95\% confidence intervals. Calibration measures not presented for Chakraborty 2008 due to no relapse events. Calibration slope not presented for Rijal 2010(A) due to only one relapse event and few total participants leading to failure of model convergence.}
  \label{fig:isc_forestCalM1}
\end{figure}
